Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sveta Padmanabhan
Institution:
St. John's University
Observed institutions:
St. John's University,
St. John's University,
TScan Therapeutics (United States)
OpenAlex ID:
A5086887694
IFNγ-induced PD-L1 expression in ovarian cancer cells is regulated by JAK1, STAT1 and IRF1 signaling
2022
·
Sveta Padmanabhan
, Bijaya Gaire
, et al.
·
Cellular Signalling
·
57
The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cells
2018
·
Yue Zou
, Mohammad M. Uddin
, et al.
·
Journal of Biological Chemistry
·
56
PDF
IFNγ induces JAK1/STAT1/p65 NFκB-dependent interleukin-8 expression in ovarian cancer cells, resulting in their increased migration
2021
·
Sveta Padmanabhan
, Bijaya Gaire
, et al.
·
The International Journal of Biochemistry & Cell Biology
·
23
IFNγ induces Bcl3 expression by JAK1/STAT1/p65 signaling, resulting in increased IL‐8 expression in ovarian cancer cells
2023
·
Bijaya Gaire
, Sveta Padmanabhan
, et al.
·
FEBS Open Bio
·
13
PDF
Flow Cytometry Analysis of Surface PD-L1 Expression Induced by IFNγ and Romidepsin in Ovarian Cancer Cells
2020
·
Sveta Padmanabhan
, Yue Zou
, et al.
·
Methods in molecular biology
·
9
Immunoblotting Analysis of Intracellular PD-L1 Levels in Interferon-γ-Treated Ovarian Cancer Cells Stably Transfected with Bcl3 shRNA
2020
·
Sveta Padmanabhan
, Yue Zou
, et al.
·
Methods in molecular biology
·
7
Analysis of PD-L1 Transcriptional Regulation in Ovarian Cancer Cells by Chromatin Immunoprecipitation
2020
·
Yue Zou
, Sveta Padmanabhan
, et al.
·
Methods in molecular biology
·
4
Interferon‐γ Induces PD‐L1 Expression in Ovarian Cancer Cells by JAK/STAT1 Signaling
2020
·
Sveta Padmanabhan
, Bijaya Gaire
, et al.
·
The FASEB Journal
·
2
376 Overcoming tumor heterogeneity – Clinical trial assays to prospectively assign patients customized multiplexed TCR-T cell therapy in Phase 1
2023
·
Ribhu Nayar
, Shazad A Khokhar
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
364 Non-clinical development of T-Plex component TSC-200-A0201: a natural HPV16 E7-specific TCR-T cell therapy for the treatment of HPV16-positive solid tumors
2023
·
Sonal Jangalwe
, Badr Kiaf
, et al.
·
Journal for ImmunoTherapy of Cancer
·
1
PDF
Interferon‐γ Induced PD‐L1 Expression in Ovarian Cancer Cells is Regulated by IRF1 Signaling
2022
·
Sveta Padmanabhan
, Bijaya Gaire
, et al.
·
The FASEB Journal
·
1
Increased Heme Synthesis in Ovarian Cancer and Triple Negative Breast Cancer Cells Leads to Downregulation of Glycolysis, Mitochondrial Respiration, and Cell Migration.
2020
·
Pritpal Kaur
, Shreya Nagar
, et al.
·
The FASEB Journal
·
1
Flow Cytometry Analysis of IFNγ-Induced PD-L1 Cell Surface Expression in Ovarian Cancer Cells
2026
·
Sveta Padmanabhan
, Yue Zou
, et al.
·
Methods in molecular biology
384 Development of a target agnostic platform to assess the reactivity of T cell receptor (TCR)- engineered T cell (TCR-T) therapies to primary human tissues
2024
·
Sveta Padmanabhan
, Shubhangi Kamalia
, et al.
·
Journal for ImmunoTherapy of Cancer
390 Discovery of MAGE-A1-specific TCR-T cell therapy candidates to expand multiplex therapy of solid tumors
2023
·
Jenny Tadros
, Nancy Nabilsi
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
Interferon‐γ Induces Bcl3 Expression in Ovarian Cancer Cells by JAK1/STAT1 Signaling
2022
·
Bijaya Gaire
, Sveta Padmanabhan
, et al.
·
The FASEB Journal
Proteasome Inhibition Increases Interleukin‐8 Expression in Triple Negative Breast Cancer Cells, Resulting in Their Increased Survival, Proliferation, and Migration
2019
·
Mohammad Uddin
, Yue Zou
, et al.
·
The FASEB Journal
Interferon Induces Expression of the Immune Checkpoint PD‐L1 via Bcl3 Upregulation in Ovarian Cancer Cells
2019
·
Yue Zou
, Mohammad Uddin
, et al.
·
The FASEB Journal
Show more works
View as search
Works count:
18
Citation count:
175
H-index:
6
I10-index:
4
Year
Topic
Type